Previous studies of the environment and cancer have focused on etiology, showing that extrinsic factors in the environment contribute to 70% to 90% of cancers. Cancer patients and survivors often continue to live in the same neighborhoods they resided in before their cancer diagnosis. Thus, patients and survivors are exposed to the same environmental contexts that likely contributed to their original cancer, but little is known about the health effects of continued exposure to carcinogens after a cancer diagnosis. This commentary provides a summary of studies of the association between PM2.5 and cancer mortality among patients and PM2.5 and posttreatment morbidity among cancer survivors, and proposes new directions and opportunities for future research on such topics.

See all articles in this CEBP Focus section, “Environmental Carcinogenesis: Pathways to Prevention.”

In this special section of Cancer Epidemiology, Biomarkers & Prevention, there are several reports detailing the importance of environmental exposures on cancer etiology. The majority of research has focused on pollutants as a risk factor for new cancer development. However, cancer patients and survivors are exposed to environmental pollutants across their course of care and throughout survivorship. Environmental pollutants and other extrinsic factors contribute to an estimated 70% to 90% of cancers in humans (1), including ambient air pollution, which has been declared carcinogenic to humans (2). Since 2016, emissions of ambient air pollution across the United States have increased, and with it an additional estimated 10,000 deaths in geographic regions where air pollution has worsened (3, 4). The majority of cancer patients and survivors continue to live in the same place they resided in before their diagnosis (5). Their unchanged environmental context contains pollutants and other extrinsic factors that likely contributed to their initial cancer. We propose broadening the scope of understanding of air pollution's effect on cancer from cancer etiology to include examinations of the effects of air pollution on the health of cancer patients during treatment and through survivorship. We suggest three key research priorities that are important for understanding the relationship between air pollution, cancer morbidity, and cancer mortality.

PM2.5 is the most often studied environmental carcinogen in the context of cancer patient mortality thus far (6–11). Exposure to PM2.5 after diagnosis is associated with a significant increase in the risk for mortality among adult patients with lung, breast, kidney, bladder, and liver cancer even after controlling for socioeconomic status, race, and stage at diagnosis (6–13). In this issue, we report significant associations between PM2.5 and mortality among adolescent and young adult patients with central nervous system, breast, melanoma, and colorectal cancers, and mortality in patients with pediatric lymphoma, lymphoid leukemia, and central nervous system tumors. However, little is known about the timing of PM2.5 exposure that may be most critical to patient outcomes or the biological mechanisms at play. Proposed mechanisms by which PM2.5 may lead to cancer mortality are similar to those that induce or promote the original cancer, including genotoxic and epigenetic alterations, inflammation, xenogeneic effects or hormone dysregulation, or by reducing the immune system's ability to fight the cancer (6–10). These mechanisms may also reduce the tumor's sensitivity to cancer treatment, which is a novel mechanism unique to patients with cancer.

Studies of PM2.5 and cancer mortality that incorporate molecular markers and measures of cancer aggressiveness can enrich our understanding of the underlying mechanisms leading to mortality. For example, comparing the association of PM2.5 and mortality in patients with ER+, PR+, or HER2+ breast cancer to mortality among patients with triple-negative breast cancers would provide more information about whether PM2.5 is operating through hormonal pathways. Our article in this issue and other studies of adult cancers report that the association of PM2.5 and mortality is higher among patients diagnosed with early-stage tumors (10, 11). Longitudinal measures of tumor aggressiveness would provide needed information about the effects of PM2.5 on cancer progression in these early-stage tumors (14, 15). Studies of PM2.5 and recurrent cancers are rare (11), but PM2.5 may be associated with overall recurrence, more aggressive recurrent cancers, and mortality from these recurrent cancers. Studies should also expand the types of pollutants studied to include the other five criteria air pollutants and air toxics.

Air pollution and cancer treatments are associated with morbidity and mortality from the same underlying pulmonary and cardiovascular diseases (Table 1), yet little is known about the effects of dual exposure to these two risk factors among cancer patients and survivors. Pulmonary and cardiovascular diseases are among the leading noncancer causes of death among cancer patients and survivors (16–27). These diseases are a product of the pulmonary-toxic and cardiotoxic effects of chest radiation, surgeries, and certain chemotherapies used to treat cancer (18, 28). Because of these treatment-induced physiologic vulnerabilities, cancer survivors and patients may be more susceptible to pollution-related pulmonary or cardiovascular morbidity and mortality than the general public (29).

The idea that cancer treatments can produce significant physiologic vulnerability to environmental pollutants is novel. Our earlier case-crossover study was the first to examine effect modification of the association of PM2.5 by cancer treatment in relation to childhood cancer survivor morbidity (29). We found that childhood cancer survivors treated with chemotherapy have significantly higher odds for a respiratory hospitalization after exposure to PM2.5 than the general public. Young adult and older adult cancer patients also suffer from treatment-related pulmonary and cardiovascular diseases and are at high risk for pulmonary and cardiovascular death (20, 30). For example, patients with breast cancer with triple-negative tumors are at extremely high risk for cardiovascular illness and death due to the chemotherapy and chest radiation used in their treatment (20, 30). Yet, no studies have examined effect modification or interaction of PM2.5 or other pollutants by cancer treatments in relation to morbidity or mortality in adults.

Despite the potential for adverse effects, cancer treatments are necessary to save lives. In contrast, patient exposure to environmental pollutants is completely unneeded and preventable through the enforcement of air quality standards that protect the public. We advocate for more studies of the consequences of exposure to environmental pollutants on the noncancer morbidity and mortality among cancer patients and survivors, with a focus on effect modification of this association by different cancer treatments.

Racial and ethnic minorities often live in more polluted neighborhoods and have reduced cancer survival compared with non-Hispanic White populations (31–38). Clinical studies of racial and ethnic disparities in cancer survival and posttreatment morbidity acknowledge that individual differences, such as tumor biology and healthcare access, are important contributors to excess disease and death (31–38). Studies of the effects of the environment on cancer survivor health have primarily been focused on the built environment (e.g., street connectivity, healthy food availability; refs. 39–41) or the social environment as measured by ethnic enclaves, ethnic density, or racial residential segregation (42–44). These studies acknowledge that neighborhoods with a higher percent of racial and ethnic minorities have more exposure to traffic-based air pollution and air toxics, which is a pattern also found in nationwide studies reporting disproportionately higher exposure to environmental pollutants among minority populations (45–47). To our best knowledge, the direct association of pollution exposure with morbidity and mortality among cancer patients and survivors who are racial and ethnic minorities has not been addressed in any studies.

To our best knowledge, no federal funding mechanisms from the NIH have been awarded to investigators studying the effect of environmental carcinogens on cancer patients or survivors. We conducted a search of research studies funded by the NIH with the words “air pollution” and “cancer” in the project terms, title, and abstract between fiscal years 2010 and 2020, including active and inactive projects. All but one of the 68 funded studies were limited to pollution and cancer etiology or studies of exposure assessment. The one study of the environment and cancer survival focused on racial segregation and racism as measures of the environment. At the same time, greater investments in surveillance of recurrent cancers, chemotherapy and radiation doses as reported electronic treatment records, and recording of cancer patient residential histories are needed to accomplish such research. Claims data merged with cancer incidence data, such as SEER-Medicare, may be a good resource for such research, but do not provide coverage of cancer patients under the age of 65. Because young adult patients with cancer and survivors of childhood cancers may be at risk for PM2.5-related health problems, new data sources to study these younger populations are needed. Although research along this topic may prove challenging, improved funding opportunities and data resources can facilitate the growth of studies that examine how environmental carcinogens and other pollutants are associated with the health outcomes of cancer patients and survivors.

As our understanding of the adverse effects of air pollution has grown, so has our knowledge of its particularly adverse effect in special populations. Those populations are currently defined by age (children and older adults), preexisting lung or heart disease, specific genetic polymorphisms, and low socioeconomic status (48). More studies are needed to determine whether cancer survivors should be considered a susceptible population. Cancer patients and survivors may be candidates for this consideration on the basis that cancer may increase their susceptibility to pollution-related mortality, and prior exposure to treatment with pulmonary and cardiotoxic therapies may also increase their risk for pollution-related morbidity.

The passing of health-based regulatory standards for the six criteria air pollutants and the recognition of air pollution as a carcinogen were significant victories for public health. Yet, new scientific studies are continually needed to support evidence-based public health policies while pushing the boundaries of what we know. Identifying new vulnerable populations is one way to strengthen the case for better policies surrounding air pollution and other environmental pollutants linked to cancer mortality, aggressiveness, and recurrence (15, 49). Nearly 17 million people in the United States have ever been diagnosed with cancer and the number of people who survive cancer is growing with advances in detection and treatment (50). Although etiology is still vital to study, it is time forge onward and examine environmental carcinogenesis across the full cancer continuum.

No potential conflicts of interest were disclosed.

This work was supported by the NIH/NCI Cancer Center Support Grant (5P30CA042014; principal investigator: Cornelia Ulrich), NIH Academic Career Development Award (K07 CA230150; to H.A. Hanson), and the Huntsman Cancer Foundation.

1.
Wu
S
,
Powers
S
,
Zhu
W
,
Hannun
YA
. 
Substantial contribution of extrinsic risk factors to cancer development
.
Nature
2016
;
529
:
43
7
.
2.
International Agency for Research on Cancer
. 
Outdoor air pollution
.
IARC Monogr Eval Carcinog Risks Hum
2016
;
109
:
9
444
.
3.
Clay
K
,
Muller
NZ
. 
Recent increases in air pollution: evidence and implications for mortality
.
Cambridge (MA): National Bureau of Economic Research
; 
2019
.
NBER Working Paper No. 26381. Available from: https://www.nber.org/papers/w26381
.
4.
Ingraham
C
. 
Air pollution is getting worse, and data show more people are dying
.
The Washington Post
. 
2019 Dec 19
.
Available from
: https://www.washingtonpost.com/business/2019/10/23/air-pollution-is-getting-worse-data-show-more- people-are-dying/.
5.
Muralidhar
V
,
Nguyen
PL
,
Tucker-Seeley
RD
. 
Recent relocation and decreased survival following a cancer diagnosis
.
Prev Med
2016
;
89
:
245
50
.
6.
Hu
H
,
Dailey
AB
,
Kan
H
,
Xu
X
. 
The effect of atmospheric particulate matter on survival of breast cancer among US females
.
Breast Cancer Res Treat
2013
;
139
:
217
26
.
7.
Huo
Q
,
Zhang
N
,
Wang
X
,
Jiang
L
,
Ma
T
,
Yang
Q
. 
Effects of ambient particulate matter on human breast cancer: is xenogenesis responsible?
PLoS One
2013
;
8
:
e76609
.
8.
Tagliabue
G
,
Borgini
A
,
Tittarelli
A
,
van Donkelaar
A
,
Martin
RV
,
Bertoldi
M
, et al
Atmospheric fine particulate matter and breast cancer mortality: a population-based cohort study
.
BMJ Open
2016
;
6
:
e012580
.
9.
Deng
H
,
Eckel
SP
,
Liu
L
,
Lurmann
FW
,
Cockburn
MG
,
Gilliland
FD
. 
Particulate matter air pollution and liver cancer survival
.
Int J Cancer
2017
;
141
:
744
9
.
10.
Eckel
SP
,
Cockburn
M
,
Shu
YH
,
Deng
H
,
Lurmann
FW
,
Liu
L
, et al
Air pollution affects lung cancer survival
.
Thorax
2016
;
71
:
891
8
.
11.
DuPre
NC
,
Hart
JE
,
Holmes
MD
,
Poole
EM
,
James
P
,
Kraft
P
, et al
Particulate matter and traffic-related exposures in relation to breast cancer survival
.
Cancer Epidemiol Biomarkers Prev
2019
;
28
:
751
9
.
12.
Turner
MC
,
Krewski
D
,
Diver
WR
,
Pope
CA
 III
,
Burnett
RT
,
Jerrett
M
, et al
Ambient air pollution and cancer mortality in the cancer prevention study II
.
Environ Health Perspect
2017
;
125
:
087013
.
13.
Kim
HB
,
Shim
JY
,
Park
B
,
Lee
YJ
. 
Long-term exposure to air pollutants and cancer mortality: a meta-analysis of cohort studies
.
Int J Environ Res Public Health
2018
;
15
. pii:
2608
.
14.
Liu
S
,
Li
S
,
Du
Y
. 
Polychlorinated biphenyls (PCBs) enhance metastatic properties of breast cancer cells by activating Rho-associated kinase (ROCK)
.
PLoS One
2010
;
5
:
e11272
e
.
15.
Demers
A
,
Ayotte
P
,
Brisson
J
,
Dodin
S
,
Robert
J
,
Dewailly
É
. 
Risk and aggressiveness of breast cancer in relation to plasma organochlorine concentrations
.
Cancer Epidemiol Biomarkers Prev
2000
;
9
:
161
6
.
16.
Fossa
SD
,
Gilbert
E
,
Dores
GM
,
Chen
J
,
McGlynn
KA
,
Schonfeld
S
, et al
Noncancer causes of death in survivors of testicular cancer
.
J Natl Cancer Inst
2007
;
99
:
533
44
.
17.
Carver
JR
,
Shapiro
CL
,
Ng
A
,
Jacobs
L
,
Schwartz
C
,
Virgo
KS
, et al
American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects
.
J Clin Oncol
2007
;
25
:
3991
4008
.
18.
Mertens
AC
,
Yasui
Y
,
Liu
Y
,
Stovall
M
,
Hutchinson
R
,
Ginsberg
J
, et al
Pulmonary complications in survivors of childhood and adolescent cancer: a report from the childhood cancer survivor study
.
Cancer
2002
;
95
:
2431
41
.
19.
Hooning
MJ
,
Aleman
BM
,
van Rosmalen
AJ
,
Kuenen
MA
,
Klijn
JG
,
van Leeuwen
FE
. 
Cause-specific mortality in long-term survivors of breast cancer: a 25-year follow-up study
.
Int J Radiat Oncol Biol Phys
2006
;
64
:
1081
91
.
20.
Aleman
BMP
,
Moser
EC
,
Nuver
J
,
Suter
TM
,
Maraldo
MV
,
Specht
L
, et al
Cardiovascular disease after cancer therapy
.
EJC Suppl
2014
;
12
:
18
28
.
21.
Chen
CL
. 
Cardiovascular prevention in the cancer survivor
.
Curr Atheroscler Rep
2015
;
17
:
484
.
22.
Doyle
JJ
,
Neugut
AI
,
Jacobson
JS
,
Grann
VR
,
Hershman
DL
. 
Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study
.
J Clin Oncol
2005
;
23
:
8597
605
.
23.
Jacob
S
,
Pathak
A
,
Franck
D
,
Latorzeff
I
,
Jimenez
G
,
Fondard
O
, et al
Early detection and prediction of cardiotoxicity after radiation therapy for breast cancer: the BACCARAT prospective cohort study
.
Radiat Oncol
2016
;
11
:
54
.
24.
Theodoulou
M
,
Seidman
AD
. 
Cardiac effects of adjuvant therapy for early breast cancer
.
Semin Oncol
2003
;
30
:
730
9
.
25.
Haugnes
HS
,
Oldenburg
J
,
Bremnes
RM
. 
Pulmonary and cardiovascular toxicity in long-term testicular cancer survivors
.
Urol Oncol
2015
;
33
:
399
406
.
26.
Huang
TT
,
Chen
Y
,
Dietz
AC
,
Yasui
Y
,
Donaldson
SS
,
Stokes
DC
, et al
Pulmonary outcomes in survivors of childhood central nervous system malignancies: a report from the childhood cancer survivor study
.
Pediatr Blood Cancer
2014
;
61
:
319
25
.
27.
Huang
TT
,
Hudson
MM
,
Stokes
DC
,
Krasin
MJ
,
Spunt
SL
,
Ness
KK
. 
Pulmonary outcomes in survivors of childhood cancer: a systematic review
.
Chest
2011
;
140
:
881
901
.
28.
National Cancer Policy Forum; Board on Health Care Services; A Livestrong and Institute of Medicine Workshop; Institute of Medicine
.
Identifying and addressing the needs of adolescents and young adults with cancer: workshop summary
.
Washington (DC)
:
National Academies Press
; 
2014
.
29.
Ou
JY
,
Hanson
HA
,
Ramsay
JM
,
Leiser
CL
,
Zhang
Y
,
VanDerslice
JA
, et al
Fine particulate matter and respiratory healthcare encounters among survivors of childhood cancers
.
Int J Environ Res Public Health
2019
;
16
.
pii:
E1081
.
30.
Boekel
NB
,
Schaapveld
M
,
Gietema
JA
,
Russell
NS
,
Poortmans
P
,
Theuws
JC
, et al
Cardiovascular disease risk in a large, population-based cohort of breast cancer survivors
.
Int J Radiat Oncol Biol Phys
2016
;
94
:
1061
72
.
31.
Cancer Disparities; [about 9 screens]
. Available from: https://www.cancer.gov/about-cancer/understanding/disparities#contributing-factors.
32.
O'Keefe
EB
,
Meltzer
JP
,
Bethea
TN
. 
Health disparities and cancer: racial disparities in cancer mortality in the United States, 2000–2010
.
Front Public Health
2015
;
3
:
51
.
33.
Bhatia
S
. 
Disparities in cancer outcomes: lessons learned from children with cancer
.
Pediatr Blood Cancer
2011
;
56
:
994
1002
.
34.
Calaminus
G
,
Joffe
J
. 
Germ cell tumors in adolescents and young adults
.
Prog Tumor Res
2016
;
43
:
115
27
.
35.
Kahn
JM
,
Keegan
TH
,
Tao
L
,
Abrahao
R
,
Bleyer
A
,
Viny
AD
. 
Racial disparities in the survival of American children, adolescents, and young adults with acute lymphoblastic leukemia, acute myelogenous leukemia, and Hodgkin lymphoma
.
Cancer
2016
;
122
:
2723
30
.
36.
Kirchhoff
AC
,
Lyles
CR
,
Fluchel
M
,
Wright
J
,
Leisenring
W
. 
Limitations in health care access and utilization among long-term survivors of adolescent and young adult cancer
.
Cancer
2012
;
118
:
5964
72
.
37.
Warner
EL
,
Nam
GE
,
Zhang
Y
,
McFadden
M
,
Wright
J
,
Spraker-Perlman
H
, et al
Health behaviors, quality of life, and psychosocial health among survivors of adolescent and young adult cancers
.
J Cancer Surviv
2016
;
10
:
280
90
.
38.
Ellis
L
,
Canchola
AJ
,
Spiegel
D
,
Ladabaum
U
,
Haile
R
,
Gomez
SL
. 
Racial and ethnic disparities in cancer survival: the contribution of tumor, sociodemographic, institutional, and neighborhood characteristics
.
J Clin Oncol
2018
;
36
:
25
33
.
39.
Wray
AJD
,
Minaker
LM
. 
Is cancer prevention influenced by the built environment? A multidisciplinary scoping review
.
Cancer
2019
;
125
:
3299
311
.
40.
Shariff-Marco
S
,
Von Behren
J
,
Reynolds
P
,
Keegan
TH
,
Hertz
A
,
Kwan
ML
, et al
Impact of social and built environment factors on body size among breast cancer survivors: the pathways study
.
Cancer Epidemiol Biomarkers Prev
2017
;
26
:
505
15
.
41.
Gomez
SL
,
Shariff-Marco
S
,
DeRouen
M
,
Keegan
THM
,
Yen
IH
,
Mujahid
M
, et al
The impact of neighborhood social and built environment factors across the cancer continuum: current research, methodological considerations, and future directions
.
Cancer
2015
;
121
:
2314
30
.
42.
McCullough
LE
,
Flowers
CR
. 
Identifying and addressing disparities in survival outcomes for rural patients with cancer
.
JAMA Network Open
2018
;
1
:
e181243
.
43.
Landrine
H
,
Corral
I
,
Lee
JGL
,
Efird
JT
,
Hall
MB
,
Bess
JJ
. 
Residential segregation and racial cancer disparities: a systematic review
.
J Racial Ethn Health Disparities
2017
;
4
:
1195
205
.
44.
Zhou
Y
,
Bemanian
A
,
Beyer
KM
. 
Housing discrimination, residential racial segregation, and colorectal cancer survival in southeastern Wisconsin
.
Cancer Epidemiol Biomarkers Prev
2017
;
26
:
561
8
.
45.
Hipp
JR
,
Lakon
CM
. 
Social disparities in health: disproportionate toxicity proximity in minority communities over a decade
.
Health Place
2010
;
16
:
674
83
.
46.
Pratt
GC
,
Vadali
ML
,
Kvale
DL
,
Ellickson
KM
. 
Traffic, air pollution, minority and socio-economic status: addressing inequities in exposure and risk
.
Int J Environ Res Public Health
2015
;
12
:
5355
72
.
47.
Grineski
SE
,
Collins
TW
. 
Geographic and social disparities in exposure to air neurotoxicants at U.S. public schools
.
Environ Res
2018
;
161
:
580
7
.
48.
Mead
MN
. 
Who's at risk? Gauging susceptibility to air pollutants
.
Environ Health Perspect
2011
;
119
:
A176
.
49.
Gray
JM
,
Rasanayagam
S
,
Engel
C
,
Rizzo
J
. 
State of the evidence 2017: an update on the connection between breast cancer and the environment
.
Environ Health
2017
;
16
:
94
.
50.
Miller
KD
,
Nogueira
L
,
Mariotto
AB
,
Rowland
JH
,
Yabroff
KR
,
Alfano
CM
, et al
Cancer treatment and survivorship statistics, 2019
.
CA Cancer J Clin
2019
;
69
:
363
85
.
51.
Pope
CA
 III
. 
Epidemiology of fine particulate air pollution and human health: biologic mechanisms and who's at risk?
Environ Health Perspect
2000
;
108
:
713
23
.
52.
Schwartz
J
. 
Air pollution and children's health
.
Pediatrics
2004
;
113
:
1037
43
.
53.
American Academy of Pediatrics
. 
Ambient air pollution: health hazards to children
.
Pediatrics
2004
;
114
:
1699
707
.
54.
Armenian
SH
,
Landier
W
,
Francisco
L
,
Herrera
C
,
Mills
G
,
Siyahian
A
, et al
Long-term pulmonary function in survivors of childhood cancer
.
J Clin Oncol
2015
;
33
:
1592
600
.
55.
de Jong
K
,
Vonk
JM
,
Zijlema
WL
,
Stolk
RP
,
van der Plaat
DA
,
Hoek
G
, et al
Air pollution exposure is associated with restrictive ventilatory patterns
.
Eur Respir J
2016
;
48
:
1221
4
.
56.
Hooper
LG
,
Young
MT
,
Keller
JP
,
Szpiro
AA
,
O'Brien
KM
,
Sandler
DP
, et al
Ambient air pollution and chronic bronchitis in a cohort of U.S. women
.
Environ Health Perspect
2018
;
126
:
027005
.
57.
Jones
MG
,
Richeldi
L
. 
Air pollution and acute exacerbations of idiopathic pulmonary fibrosis: back to miasma?
Eur Respir J
2014
;
43
:
956
9
.
58.
Pirozzi
CS
,
Jones
B
,
VanDerslice
JA
,
Zhang
Y
,
Paine
R
 III
,
Dean
NC
. 
Short-term effects of particulate air pollution exposure on incidence and severity of pneumonia
.
Ann Am Thorac Soc
2018
;
15
:
449
59
.
59.
Pope
CA
,
Muhlestein
JB
,
May
HT
,
Renlund
DG
,
Anderson
JL
,
Horne
BD
. 
Ischemic heart disease events triggered by short-term exposure to fine particulate air pollution
.
Circulation
2006
;
114
:
2443
8
.
60.
Carver
JR
,
Szalda
D
,
Ky
B
. 
Asymptomatic cardiac toxicity in long-term cancer survivors: defining the population and recommendations for surveillance
.
Semin Oncol
2013
;
40
:
229
38
.
61.
Shah
AS
,
Langrish
JP
,
Nair
H
,
McAllister
DA
,
Hunter
AL
,
Donaldson
K
, et al
Global association of air pollution and heart failure: a systematic review and meta-analysis
.
Lancet
2013
;
382
:
1039
48
.
62.
Cai
Y
,
Zhang
B
,
Ke
W
,
Feng
B
,
Lin
H
,
Xiao
J
, et al
Associations of short-term and long-term exposure to ambient air pollutants with hypertension: a systematic review and meta-analysis
.
Hypertension
2016
;
68
:
62
70
.
63.
Bourdrel
T
,
Bind
MA
,
Béjot
Y
,
Morel
O
,
Argacha
JF
. 
Cardiovascular effects of air pollution
.
Arch Cardiovasc Dis
2017
;
110
:
634
42
.
64.
Shepard
CW
,
Steinberger
J
. 
Premature atherosclerotic cardiovascular disease in childhood cancer survivors
.
Prog Pediatr Cardiol
2015
;
39
:
59
66
.
65.
Whitlock
MC
,
Yeboah
J
,
Burke
GL
,
Chen
H
,
Klepin
HD
,
Hundley
WG
. 
Cancer and its association with the development of coronary artery calcification: an assessment from the multiethnic study of atherosclerosis
.
J Am Heart Assoc
2015
;
4
.
pii
:
e002533
.
66.
Araujo
JA
. 
Particulate air pollution, systemic oxidative stress, inflammation, and atherosclerosis
.
Air Qual Atmos Health
2010
;
4
:
79
93
.
67.
Haugnes
HS
,
Wethal
T
,
Aass
N
,
Dahl
O
,
Klepp
O
,
Langberg
CW
, et al
Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study
.
J Clin Oncol
2010
;
28
:
4649
57
.
68.
Ruckerl
R
,
Ibald-Mulli
A
,
Koenig
W
,
Schneider
A
,
Woelke
G
,
Cyrys
J
, et al
Air pollution and markers of inflammation and coagulation in patients with coronary heart disease
.
Am J Respir Crit Care Med
2006
;
173
:
432
41
.
69.
Simkhovich
BZ
,
Kleinman
MT
,
Kloner
RA
. 
Particulate air pollution and coronary heart disease
.
Curr Opin Cardiol
2009
;
24
:
604
9
.
70.
Dardiotis
E
,
Aloizou
A-M
,
Markoula
S
,
Siokas
V
,
Tsarouhas
K
,
Tzanakakis
G
, et al
, 
Cancer-associated stroke: pathophysiology, detection and management (review)
.
Int J Oncol
2019
;
54
:
779
96
.
71.
Dearborn
JL
,
Urrutia
VC
,
Zeiler
SR
. 
Stroke and cancer- a complicated relationship
.
J Neurol Transl Neurosci
2014
;
2
:
1039
.
72.
Chen
YC
,
Weng
YH
,
Chiu
YW
,
Yang
CY
. 
Short-term effects of coarse particulate matter on hospital admissions for cardiovascular diseases: a case-crossover study in a tropical city
.
J Toxicol Environ Health A
2015
;
78
:
1241
53
.
73.
Du
Y
,
Xu
X
,
Chu
M
,
Guo
Y
,
Wang
J
. 
Air particulate matter and cardiovascular disease: the epidemiological, biomedical and clinical evidence
.
J Thorac Dis
2016
;
8
:
E8
E19
.
74.
Simkhovich
BZ
,
Kleinman
MT
,
Kloner
RA
. 
Air pollution and cardiovascular injury: epidemiology, toxicology, and mechanisms
.
J Am Coll Cardiol
2008
;
52
:
719
26
.